{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:50:18Z","timestamp":1781808618460,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K27387"],"award-info":[{"award-number":["23K27387"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.prp.2025.156270","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:58:56Z","timestamp":1760543936000},"page":"156270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Automated spatial analysis reveals proximity of human leukocyte antigen class I-positive tumor cells and CD8-positive cells of the tumor microenvironment in stage I seminoma"],"prefix":"10.1016","volume":"276","author":[{"given":"Takuto","family":"Ogasawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-2551","authenticated-orcid":false,"given":"Terufumi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Shijubou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohide","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Hirohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prp.2025.156270_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ije\/15.2.164","article-title":"Testicular cancer in the United States: trends in incidence and mortality","volume":"15","author":"Brown","year":"1986","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.prp.2025.156270_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21037\/tau-22-521","article-title":"Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study","volume":"12","author":"Ozaki","year":"2023","journal-title":"Transl. Androl. Urol."},{"issue":"22","key":"10.1016\/j.prp.2025.156270_bib3","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2025.156270_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jnci\/djq525","article-title":"Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up","volume":"103","author":"Mead","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.prp.2025.156270_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jnci\/djq535","article-title":"Stage I seminoma: adjuvant treatment is effective but is it necessary?","volume":"103","author":"Chung","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"19","key":"10.1016\/j.prp.2025.156270_bib6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.prp.2025.156270_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.prp.2025.156270_bib8","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.prp.2025.156270_bib9","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.prp.2025.156270_bib10","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.prp.2025.156270_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.1701044","article-title":"Inhibitors of the PD-1 pathway in tumor therapy","volume":"200","author":"LaFleur","year":"2018","journal-title":"J. Immunol."},{"issue":"S2","key":"10.1016\/j.prp.2025.156270_bib12","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0893-3952(22)04459-3","article-title":"Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues","volume":"18","author":"Ulbright","year":"2005","journal-title":"Mod. Pathol."},{"issue":"15","key":"10.1016\/j.prp.2025.156270_bib13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0959-8049(02)00235-6","article-title":"The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance","volume":"38","author":"Parker","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2025.156270_bib14","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41416-024-02669-9","article-title":"T cells in testicular germ cell tumors: new evidence of fundamental contributions by rare subsets","volume":"130","author":"Islam","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156270_bib15","article-title":"Immune checkpoint inhibitors in patients with testicular cancer: a systematic review","author":"Salazar-Mej\u00eda","year":"2024","journal-title":"J. Adolesc. Young.. Adult Oncol."},{"key":"10.1016\/j.prp.2025.156270_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejca.2023.04.012","article-title":"Efficacy of immune checkpoint inhibitors in microsatellite unstable\/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO european cohort","volume":"188","author":"Ta\u00efeb","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2025.156270_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.prp.2025.156270_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02767657","article-title":"Burned-out tumour of the testis presenting as retroperitoneal choriocarcinoma","volume":"26","author":"Lopez","year":"1994","journal-title":"Int. Urol. Nephrol."},{"issue":"9","key":"10.1016\/j.prp.2025.156270_bib19","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1349-7006.2007.00558.x","article-title":"HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer","volume":"98","author":"Kikuchi","year":"2007","journal-title":"Cancer Sci."},{"issue":"13","key":"10.1016\/j.prp.2025.156270_bib20","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/0959-8049(93)90545-Q","article-title":"Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens","volume":"29A","author":"Nouri","year":"1993","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2025.156270_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15472","article-title":"Assessment of cancer cell-expressed HLA class I molecules and their immunopathological implications","volume":"103","author":"Kubo","year":"2024","journal-title":"HLA"},{"issue":"2","key":"10.1016\/j.prp.2025.156270_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcp\/93.2.202","article-title":"The expression of HLA class I antigens in germ cell testicular cancer","volume":"93","author":"Klein","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"issue":"115755","key":"10.1016\/j.prp.2025.156270_bib23","article-title":"Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis","volume":"229","author":"Mandal\u00e0","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156270_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13244","article-title":"A gene signature for immune subtyping of desert, excluded, and inflamed ovarian tumors","volume":"84","author":"Mlynska","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2025.156270_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/biom14020171","article-title":"Defining melanoma immune biomarkers-desert, excluded, and inflamed subtypes-using a gene expression classifier reflecting intratumoral immune response and stromal patterns","volume":"14","author":"Mlynska","year":"2024","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.prp.2025.156270_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30779","article-title":"Spatial distance between tumor and lymphocyte can predict the survival of patients with resectable lung adenocarcinoma","volume":"10","author":"Pan","year":"2024","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.prp.2025.156270_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100259","article-title":"Spatial proximity and relative distribution of tumor-infiltrating lymphocytes and macrophages predict survival in melanoma","volume":"103","author":"De Logu","year":"2023","journal-title":"Lab Invest"},{"issue":"15","key":"10.1016\/j.prp.2025.156270_bib28","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/cancers14153682","article-title":"Bright-field multiplex immunohistochemistry assay for tumor microenvironment evaluation in melanoma tissues","volume":"14","author":"Ugolini","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.prp.2025.156270_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ijc.21894","article-title":"Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic t cells","volume":"119","author":"Hadrup","year":"2006","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2025.156270_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/his.14968","article-title":"FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type","volume":"83","author":"Ricci","year":"2023","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.prp.2025.156270_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/his.14933","article-title":"Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation","volume":"83","author":"Bremmer","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156270_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/his.15531","article-title":"Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype","author":"Grillini","year":"2025","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.prp.2025.156270_bib33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/ijc.32714","article-title":"Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate","volume":"146","author":"Jostes","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2025.156270_bib34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/cancers11050728","article-title":"TCam-2 cells deficient for SOX2 and FOXA2 are blocked in differentiation and maintain a seminoma-like cell fate in vivo","volume":"11","author":"Nettersheim","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.prp.2025.156270_bib35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ajcp\/aqab200","article-title":"Immunohistochemical expression of preferentially expressed antigen in melanoma (PRAME) in the uninvolved background testis, germ cell neoplasia in situ, and germ cell tumors of the testis","volume":"157","author":"Ricci","year":"2022","journal-title":"Am. J. Clin. Pathol."},{"issue":"154044","key":"10.1016\/j.prp.2025.156270_bib36","article-title":"SOX2 and PRAME in the \u201creprogramming\u201d of seminoma cells","volume":"237","author":"Orsatti","year":"2022","journal-title":"Pathol. Res. Pr."},{"issue":"3","key":"10.1016\/j.prp.2025.156270_bib37","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/jcmm.16222","article-title":"The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours","volume":"25","author":"Wruck","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"11","key":"10.1016\/j.prp.2025.156270_bib38","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/ijc.35385","article-title":"Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance","volume":"156","author":"Kotthoff","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2025.156270_bib39","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jcmm.13082","article-title":"The plasticity of germ cell cancers and its dependence on the cellular microenvironment","volume":"21","author":"Nettersheim","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"154540","key":"10.1016\/j.prp.2025.156270_bib40","article-title":"TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis","volume":"247","author":"Melotti","year":"2023","journal-title":"Pathol. Res. Pr."},{"key":"10.1016\/j.prp.2025.156270_bib41","article-title":"Integrated molecular analysis reveals 2 distinct subtypes of pure seminoma of the testis","volume":"21","author":"Medvedev","year":"2022","journal-title":"Cancer Inf."},{"issue":"3","key":"10.1016\/j.prp.2025.156270_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s13205-023-03530-1","article-title":"Seminoma subtypes differ in the organization and functional state of the immune microenvironment","volume":"13","author":"Savelyeva","year":"2023","journal-title":"3 Biotech"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:12:54Z","timestamp":1763446374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"alternative-id":["S0344033825004637"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156270","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated spatial analysis reveals proximity of human leukocyte antigen class I-positive tumor cells and CD8-positive cells of the tumor microenvironment in stage I seminoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156270"}}